These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37490235)

  • 1. Successful allogeneic hematopoietic stem cell transplantation in a patient with type I CD36 deficiency: a case study and literature review.
    Okuyama S; Sumi M; Ishikawa R; Shishido T; Koyama D; Ueki T; Takahashi D; Kobayashi H; Kobayashi H; Tsuno NH
    Int J Hematol; 2023 Nov; 118(5):656-660. PubMed ID: 37490235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-CD36 Mediated Platelet Transfusion Refractoriness and Related Cases After Stem Cell Transplantation].
    Zhou Y; Li LL; Zhong ZL; Liu XJ; Liu JL; Shen WD; Wu GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):541-546. PubMed ID: 29665929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of Philadelphia chromosome-positive acute lymphocytic leukaemia with type I CD36 deficiency.
    Matsui M; Kajiwara K; Tsukada M; Iwama K; Yamada K; Kodo H; Seto K; Tonami K; Ando M; Matsuhashi M; Watanabe-Okochi N; Tsuno NH; Kozai Y
    Vox Sang; 2022 Jan; 117(1):128-132. PubMed ID: 34125957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Solves P; Sanz J; Freiria C; Santiago M; Villalba A; Gómez I; Montesinos P; Montoro J; Piñana JL; Lorenzo JI; Puig N; Sanz GF; Sanz MÁ; Carpio N
    Ann Hematol; 2018 Jan; 97(1):161-167. PubMed ID: 29150812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36 immunization in a patient undergoing hematopoietic stem cell transplantation.
    Culler EE; Hillyer CD; Haight AE; Castillejo MI; Josephson CD
    Pediatr Blood Cancer; 2008 Mar; 50(3):660-2. PubMed ID: 17330834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
    Song X; Qi J; Li X; Zhou M; He J; Chu T; Han Y
    Platelets; 2023 Dec; 34(1):2229905. PubMed ID: 37409458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.
    Xu X; Ye X; Xia W; Liu J; Ding H; Deng J; Chen Y; Shao Y; Wang J; Fu Y; Santoso S
    Thromb Haemost; 2013 Dec; 110(6):1199-206. PubMed ID: 23966019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransfusion purpura following bone marrow transplantation.
    Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
    Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of platelet transfusion refractoriness due to anti-CD36 with a successful treatment outcome.
    Khatri SS; Curtis BR; Yamada C
    Immunohematology; 2019 Dec; 35(4):139-144. PubMed ID: 31935329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
    Yan CH; Liu QF; Wu DP; Zhang X; Xu LP; Zhang XH; Wang Y; Huang H; Bai H; Huang F; Ma X; Huang XJ
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1311-1319. PubMed ID: 28483716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia].
    Uchiyama Y; Hoshino T; Mihara M; Mitsui T; Koiso H; Takizawa M; Yokohama A; Saitoh T; Uchiumi H; Handa H; Tsukamoto N; Murakami H; Nojima Y
    Rinsho Ketsueki; 2013 Feb; 54(2):214-8. PubMed ID: 23470830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
    Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type.
    Subramanian S; Cohn C; DeFor T; Welbig J; Brunstein C; El Jurdi N; Weisdorf D
    Transfusion; 2021 Jul; 61(7):2064-2074. PubMed ID: 33899243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and molecular basis of CD36 deficiency among platelet donors in Kunming, China.
    Lyu Q; Peng M; Chen Q; Ji X; Wang Z; Li Q; Zhang Z; Luo Z; Yin Y; Su P; Santoso S; Wang J
    Platelets; 2023 Dec; 34(1):2176168. PubMed ID: 36813737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet Transfusion Strategies for MASPAT-Matched Platelet Transfusion Failed Patient with Allogeneic Hematopoietic Stem Cell Transplantation].
    Yang L; Ma CY; Fu LH; Tai SF; Ma MZ; Zhong XL; Fan B; Wang XX; Wang DQ; Yu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):850-854. PubMed ID: 37356950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation.
    Kurosawa S; Yamaguchi T; Nakabayashi S; Kasane M; Tsubokura M; Iwashita N; Minakawa Y; Ohtake R; Kawamura K; Nishioka Y; Takeda W; Hirakawa T; Aoki J; Ito A; Tanaka T; Inamoto Y; Kim SW; Kojima M; Takanashi M; Fukuda T
    Int J Hematol; 2021 Apr; 113(4):518-529. PubMed ID: 33392973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.
    Solh M; Brunstein C; Morgan S; Weisdorf D
    Biol Blood Marrow Transplant; 2011 May; 17(5):710-6. PubMed ID: 20813199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.